0000914190-15-000293.txt : 20150811 0000914190-15-000293.hdr.sgml : 20150811 20150811163818 ACCESSION NUMBER: 0000914190-15-000293 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20150807 FILED AS OF DATE: 20150811 DATE AS OF CHANGE: 20150811 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-TECHNE Corp CENTRAL INDEX KEY: 0000842023 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 411427402 STATE OF INCORPORATION: MN FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 614 MCKINLEY PL N E CITY: MINNEAPOLIS STATE: MN ZIP: 55413 BUSINESS PHONE: 6123798854 MAIL ADDRESS: STREET 1: 614 MCKINLEY PLACE NE CITY: MINNEAPOLIS STATE: MN ZIP: 55413 FORMER COMPANY: FORMER CONFORMED NAME: TECHNE CORP /MN/ DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kummeth Charles R. CENTRAL INDEX KEY: 0001534980 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17272 FILM NUMBER: 151044372 MAIL ADDRESS: STREET 1: 425 MARTINGALE ROAD STREET 2: SUITE 2050 CITY: SCHAUMBURG STATE: IL ZIP: 60173-2213 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2015-08-07 0000842023 BIO-TECHNE Corp TECH 0001534980 Kummeth Charles R. 614 MCKINLEY PLACE NE MINNEAPOLIS MN 55413 1 1 0 0 Chief Executive Officer Common Stock 2015-08-07 4 A 0 11522 0 A 44377 D Stock Option (Right to Buy) 67.46 2020-04-01 Common Stock 65000 65000 D Stock Option (Right to Buy) 67.46 2020-04-01 Common Stock 50000 50000 D Stock Option (Right to Buy) 86.25 2021-04-01 Common Stock 46316 46316 D Stock Option (Right to Buy) 94.35 2021-08-12 Common Stock 80460 80460 D Restricted Stock Unit Common Stock 11129 11129 D Stock Option (Right to Buy) 108.49 2015-08-07 4 A 0 79517 0 A 2022-08-07 Common Stock 79517 79517 D Stock Option (Right to Buy) 108.49 2015-08-07 4 A 0 79517 0 A 2022-08-07 Common Stock 79517 79517 D Restricted Stock Unit 2015-08-07 4 A 0 11522 0 A Common Stock 11522 11522 D Includes (i) 5,000 shares of restricted stock that vest on April 1, 2016, (ii) 5,102 shares for which the risk of forfeiture will lapse with respect to 2,551 shares on April 1, 2016 and April 1, 2017; (iii) 10,203 shares for which the risk of forfeiture will lapse pursuant to achievement of performance goals; and (iv) 11,522 shares for which the risks of forfeiture will lapse with respect to 3,840 shares on August 7, 2016 and 3,841 shares on each of August 7, 2017 and August 7, 2018. The option will vest pursuant to the following schedule: 8,125 shares on October 1, 2013, 1,354 shares on the first day of each month for the period beginning November 1, 2013 and ending March 1, 2017, and 1,361 shares on April 1, 2017. Fully exercisable pursuant to achievement of performance goals. The option will vest pursuant to the following schedule: 5,790 shares on October 1, 2014, 965 shares on the first day of the month for the period beginning November 1, 2014 and ending March 1, 2018, and 961 shares on April 1, 2018. Vests in full or in part if certain performance goals are achieved during each of the 2015, 2016 and 2017 fiscal years. Vests in full or in part if certain performance goals are achieved during each of the 2015, 2016 and 2017 fiscal years (previously reported in Table I). 19,879 shares vest on each of August 7, 2016, August 7, 2017 and August 7, 2018 and 19,880 shares vest on August 7, 2019. Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. Vests in full or in part if certain performance goals are achieved during each of the 2016, 2017 and 2018 fiscal years. /s/ Elizabeth M. Dunshee as Attorney-in-Fact for Charles R. Kummeth pursuant to Power of Attorney filed herewith. 2015-08-11 EX-24 2 kummethpoa.htm KUMMETH POWER OF ATTORNEY

POWER OF ATTORNEY



 The undersigned hereby constitutes and appoints Brenda S. Furlow,

James Hippel, Melodie R. Rose and Elizabeth M. Dunshee, or either of

them acting alone, the undersigned's true and lawful attorneys-in-fact

and agent with full power of substitution and resubstitution, for the

undersigned and in the undersigned's name, place and stead, in any and

all capacities, to sign any or all Forms 3, Forms 4 and Forms 5

relating to beneficial ownership of securities of Techne Corporation

(the "Issuer"), to file the same, with all exhibits thereto and other

documents in connection therewith, with the Securities and Exchange

Commission and to deliver a copy of the same to the Issuer, granting

unto said attorney-in-fact and agent full power and authority to do and

perform each and every act and thing requisite and necessary to be done

in and about the premises, as fully to all intents and purposes as the

undersigned might or could do in person, hereby ratifying and

confirming all said attorneys-in-fact and agent, or his substitute or

substitutes, may lawfully do or cause to be done by virtue thereof.

The undersigned acknowledges that the foregoing attorney-in-fact, in

serving in such capacity at the request of the undersigned, is not

assuming any of the undersigned's responsibilities to comply with

Section 16 of the Securities Exchange Act of 1934.



 This Power of Attorney shall remain in effect until such time as

the undersigned is no longer subject to the provisions of Section 16 of

the Securities Exchange Act of 1934 with respect to securities of the

Issuer.



 IN WITNESS WHEREOF, the undersigned has caused this Power of

Attorney to be executed as of this 30th day of October 2014.



                  /s/ Charles R. Kummeth